EP3962459A4 - Pharmazeutische zusammensetzungen mit tolperison- und nimesulidkombinationen - Google Patents

Pharmazeutische zusammensetzungen mit tolperison- und nimesulidkombinationen Download PDF

Info

Publication number
EP3962459A4
EP3962459A4 EP20798008.7A EP20798008A EP3962459A4 EP 3962459 A4 EP3962459 A4 EP 3962459A4 EP 20798008 A EP20798008 A EP 20798008A EP 3962459 A4 EP3962459 A4 EP 3962459A4
Authority
EP
European Patent Office
Prior art keywords
tolperisone
nimesulide
combinations
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20798008.7A
Other languages
English (en)
French (fr)
Other versions
EP3962459A1 (de
Inventor
Seyhan TURKKAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3962459A1 publication Critical patent/EP3962459A1/de
Publication of EP3962459A4 publication Critical patent/EP3962459A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EP20798008.7A 2019-04-30 2020-03-23 Pharmazeutische zusammensetzungen mit tolperison- und nimesulidkombinationen Pending EP3962459A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/06487A TR201906487A1 (tr) 2019-04-30 2019-04-30 Tolperi̇zon ve ni̇mesuli̇d kombi̇nasyonlari i̇çeren farmasöti̇k kompozi̇syonlar
PCT/TR2020/050229 WO2020222714A1 (en) 2019-04-30 2020-03-23 Pharmaceutical compositions comprising tolperisone and nimesulide combinations

Publications (2)

Publication Number Publication Date
EP3962459A1 EP3962459A1 (de) 2022-03-09
EP3962459A4 true EP3962459A4 (de) 2023-01-25

Family

ID=73028767

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20798008.7A Pending EP3962459A4 (de) 2019-04-30 2020-03-23 Pharmazeutische zusammensetzungen mit tolperison- und nimesulidkombinationen

Country Status (3)

Country Link
EP (1) EP3962459A4 (de)
TR (1) TR201906487A1 (de)
WO (1) WO2020222714A1 (de)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362585A2 (de) * 2001-01-26 2003-11-19 Osmotica Corp. Pharmazeutische zusammensetzungen mit einem cox-ii-hemmer und einem muskelrelaxans
WO2010103544A2 (en) * 2009-03-09 2010-09-16 Dinesh Shantilal Patel A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
WO2010128525A2 (en) * 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
WO2014125085A1 (en) * 2013-02-15 2014-08-21 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral pharmaceutical formulations comprising nimesulide and thiocolchicoside
WO2019203751A2 (en) * 2017-12-13 2019-10-24 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperisone and selective cox-2 inhibitor combinations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190963B (de) * 2000-06-20 2003-09-06 Ajanta Pharma Ltd

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362585A2 (de) * 2001-01-26 2003-11-19 Osmotica Corp. Pharmazeutische zusammensetzungen mit einem cox-ii-hemmer und einem muskelrelaxans
WO2010103544A2 (en) * 2009-03-09 2010-09-16 Dinesh Shantilal Patel A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
WO2010128525A2 (en) * 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
WO2014125085A1 (en) * 2013-02-15 2014-08-21 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral pharmaceutical formulations comprising nimesulide and thiocolchicoside
WO2019203751A2 (en) * 2017-12-13 2019-10-24 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperisone and selective cox-2 inhibitor combinations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Tolnim", 29 February 2016 (2016-02-29), XP093107210, Retrieved from the Internet <URL:https://www.buy-pharma.md/Tolnim-Nimesulide-Tolperisone-p-6110.html> [retrieved on 20231129] *
See also references of WO2020222714A1 *

Also Published As

Publication number Publication date
WO2020222714A1 (en) 2020-11-05
TR201906487A1 (tr) 2020-11-23
EP3962459A1 (de) 2022-03-09

Similar Documents

Publication Publication Date Title
EP3817722A4 (de) Pharmazeutische zusammensetzungen mit meloxicam
MA55206A (fr) Polyribonucléotides circulaires et compositions pharmaceutiques associées
EP3947353A4 (de) Pharmazeutische zusammensetzungen und kombinationen mit inhibitoren des androgenrezeptors und deren verwendungen
EP3778608A4 (de) Polycyclische carbamoylpyridonderivate, pharmazeutische zusammensetzungen und ihre verwendung
EP3881846A4 (de) Pharmazeutische zusammensetzung mit parp-inhibitoren
PT3717471T (pt) Novos compostos e composições farmacêuticas dos mesmos para o tratamento de doenças
EP3630145A4 (de) Pharmazeutische zusammensetzungen mit cannabidiol und beta-caryophyllen und verfahren zu ihrer verwendung
EP3548000A4 (de) Pharmazeutische zusammensetzungen von atropin
MA47816A (fr) Composition pharmaceutique comprenant du sélexipag
EP3906019C0 (de) Pharmazeutische zusammensetzungen von furosemid
EP4132511A4 (de) Pharmazeutische zusammensetzungen mit meloxicam
JP2018172409A5 (ja) １５−ｈｅｐｅを含む組成物および同組成物を使用する方法
EP3897593A4 (de) Cannabinoid-formulierungen und pharmazeutische zusammensetzungen
MA55015A (fr) Formulations pharmaceutiques
EP3946316A4 (de) Pharmazeutische cannabidiolzusammensetzungen
EP3914234A4 (de) Pharmazeutische zusammensetzungen
EP3777866A4 (de) Pharmazeutische zusammensetzung und verabreichung davon
DK3981390T3 (da) Farmaceutisk lacosamid-sammensætning og farmaceutisk præparat deraf
EP4023227A4 (de) Pharmazeutische zusammensetzung und verabreichung davon
EP4073071A4 (de) Verwendung und pharmazeutische zusammensetzung von phenylisoxazolylmethylen-naphthalen-ether-derivaten
EP4015001A4 (de) Orale pharmazeutische zusammensetzung
MA49837A (fr) Compositions pharmaceutiques
EP3582759A4 (de) Bioäquivalente pharmazeutische zusammensetzung von vortioxetinhydrobromid
MA45158A (fr) Composition pharmaceutique comprenant de l&#39;éteplirsen
EP3817744A4 (de) Ivosidenib-formen und pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230102

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/24 20060101ALI20221220BHEP

Ipc: A61K 47/14 20170101ALI20221220BHEP

Ipc: A61K 47/12 20060101ALI20221220BHEP

Ipc: A61K 47/02 20060101ALI20221220BHEP

Ipc: A61P 21/02 20060101ALI20221220BHEP

Ipc: A61P 29/00 20060101ALI20221220BHEP

Ipc: A61K 31/63 20060101ALI20221220BHEP

Ipc: A61K 31/18 20060101ALI20221220BHEP

Ipc: A61K 31/4453 20060101ALI20221220BHEP

Ipc: A61K 9/20 20060101AFI20221220BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231213

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET A.S.